Inhibition of poly ADP ribose polymerase (PARP) induces cell death in leukaemic cell lines alone or synergistically with histone deacetylase inhibitors: potential for anti-leukaemia therapy

被引:0
|
作者
Gaymes, T. J. [1 ]
Shall, S. [1 ]
Farzaneh, F. [1 ]
Mufti, G. J. [1 ]
机构
[1] GKT Sch Med, Rayne Inst, Dept Haematol Med, Leukaemia Sci Labs, London, England
基金
英国生物技术与生命科学研究理事会;
关键词
D O I
10.1016/S0145-2126(07)70108-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S61 / S62
页数:2
相关论文
共 50 条
  • [1] Inhibition of PoIy ADP ribose polymerase (PARP) activity exerts cytotoxic effects on chromosomal instability syndrome and leukaemic cell lines: Potential for anti-leukaemia therapy.
    Gaymes, Terry J.
    Shall, S.
    Farzaneh, Farzin
    Mufti, Ghularn J.
    BLOOD, 2006, 108 (11) : 748A - 748A
  • [2] Inhibition of Poly(ADP-Ribose) Polymerase (PARP) Induces Apoptosis in Lung Cancer Cell Lines
    Gangopadhyay, Nupur N.
    Luketich, James D.
    Opest, Amy
    Visus, Carmen
    Meyer, Ernest M.
    Landreneau, Rodney
    Schuchert, Matthew J.
    CANCER INVESTIGATION, 2011, 29 (09) : 608 - 616
  • [3] INHIBITION OF DNA TOPOISOMERASE 1 AND POLY(ADP-RIBOSE) POLYMERASE SYNERGISTICALLY INDUCES CELL DEATH IN GLIOBLASTOMA WITH PTEN LOSS
    Butler, Madison
    Su, Yu-Ting
    Hwang, Lee
    Marzi, Laetitia
    Gilbert, Mark
    Pommier, Yves
    Wu, Jing
    NEURO-ONCOLOGY, 2019, 21 : 94 - 94
  • [4] Poly ADP Whose Polymerase (PARP) Inhibitors Induce Apoptosis Alone or Synergistically with Histone Deacetylase Inhibitors in Primary Acute Myeloid Leukemic Patient Cells.
    Gaymes, Terry J.
    Shall, Sydney
    Farzaneh, Farzin
    Mufti, Ghulam J.
    BLOOD, 2008, 112 (11) : 1022 - 1022
  • [5] Identification of factors governing sensitivity of NSCLC cell lines to inhibition of Poly (ADP-Ribose) Polymerase (PARP)
    Kommajosyula, Naveen
    Moreau, Lisa
    D'Andrea, Alan D.
    Shapiro, Geoffrey I.
    CANCER RESEARCH, 2012, 72
  • [6] Poly(ADP-ribose) polymerase inhibitors in the prevention of neuronal cell death
    Larner, AJ
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (04) : 481 - 487
  • [7] Antitumor effect of a poly (ADP-ribose) polymerase (PARP) inhibitor in endometrial carcinoma cell lines
    Miyasaka, Aki
    Oda, Katsutoshi
    Ikeda, Yuji
    Kashiyama, Tomoko
    Koso, Takahiro
    Inaba, Kanako
    Fukuda, Tomohiko
    Makii, Chinami
    Asada, Kayo
    Kurikawa, Reiko
    Hiraike, Osamu Wada
    Sone, Kenbun
    Uehara, Yuriko
    Matsumoto, Yoko
    Arimoto, Takahide
    Kuramoto, Hiroyuki
    Yano, Tetsu
    Kawana, Kei
    Osuga, Yutaka
    Fujii, Tomoyuki
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death
    Herceg, Z
    Wang, ZQ
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2001, 477 (1-2) : 97 - 110
  • [9] The effect of Poly (ADP) Ribose Polymerase inhibitors on Taxol induced cell death in cultured cells
    Bognar, Z
    Varbiro, G
    Radnai, B
    Tapodi, A
    Hanto, K
    Jakus, P
    Gallyas, F
    Sumegi, B
    FEBS JOURNAL, 2005, 272 : 505 - 506
  • [10] Inhibitors of poly(ADP-ribose) polymerase (PARP) are neuroprotective against necrotic but not apoptotic post-ischemic cell death.
    Pellegrini-Giampietro, DE
    Meli, E
    Cozzi, A
    Romagnoli, P
    Pellicciari, R
    Moroni, F
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 : U40 - U40